… autologous or allogeneic MSCs are used depending on availability and suitability of the cell
source. The main obstacle in performing for allogeneic … suppressive effect of glucocorticoids …

… SLE and, however, therapeutic effect may be not permanent, … immunosuppressive property
of MSCs [68]. Patient self-derived MSCs are believed to have impaired immunosuppressive …

… High doses steroids result in altering of physicochemical … CNI-related nephrotoxicity,
therefore low doses of CNI seem … mature DC to stimulate allogenic and autologous T cells [31]. …

… Four patients were on additionally non-steroid immunosuppressive drugs. … impact on
sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, …

… effects directly related to the immunosuppressive drugs (eg, … by autologous HSCT but cured
by an allogeneic HSCT from a … , cytoxan, melphlan or low dose total body irradiation (TBI)21'…

… in the setting of autologous and allogenic HSCT for AD in … to systemic immunosuppression
with corticosteroids, which … have been described after autologous and allogeneic HSCT, …

… c Proliferative response of autologous responding T CD4 + cells in allogeneic MLR in the …
effect may contribute to immunosuppressive and anti-inflammatory property of glucocorticoids …

… Therefore, low-dose steroids may have little effect on CAR-T … HSCT, immunosuppressant
sirolimus, and TPO receptor … Previous studies have shown that glucocorticoids could inhibit the …

… to achieve complete remission prior to allogeneic hematopoietic stem cell … ) effects by virtue
of HLA class I/II donor-host disparities, but it typically requires intensive immunosuppression …

… steroids, and four out of five patients with cGVHD were disease-free and off immunosuppression.
… study, four out of five patients were free of active cGVHD and off immunosuppression. …